- Home
- DELL vs NVS Comparison
DELL vs NVS Comparison
Compare DELL & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DELL | NVS |
|---|---|---|
| Founded | 1984 | 1895 |
| Country | United States | Switzerland |
| Employees | N/A | 75267 |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.7B | 286.5B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | DELL | NVS |
|---|---|---|
| Price | $424.50 | $150.30 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 5 |
| Target Price | ★ $181.63 | $144.00 |
| AVG Volume (30 Days) | ★ 9.8M | 1.6M |
| Earning Date | 05-28-2026 | 04-28-2026 |
| Dividend Yield | 1.23% | ★ 2.16% |
| EPS Growth | ★ 36.05 | N/A |
| EPS | ★ 5.24 | N/A |
| Revenue | ★ $113,538,000,000.00 | N/A |
| Revenue This Year | $26.19 | $2.30 |
| Revenue Next Year | $8.60 | $5.27 |
| P/E Ratio | $77.15 | ★ $23.13 |
| Revenue Growth | ★ 18.80 | N/A |
| 52 Week Low | $110.22 | $112.34 |
| 52 Week High | $469.47 | $170.46 |
Technical Indicators
Market Signals| Indicator | DELL | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 67.21 | 52.60 |
| Support Level | $126.13 | $149.49 |
| Resistance Level | $469.47 | $152.55 |
| Average True Range (ATR) | 30.51 | 2.16 |
| MACD | -3.29 | 0.38 |
| Stochastic Oscillator | 54.75 | 67.71 |
Price Performance
Historical ComparisonAbout DELL Dell Technologies Inc.
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners and also relies heavily on channel partners to fulfill its sales.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.